
Continuous vs. batch production
While widely adopted in other industries, continuous manufacturing is only just starting to be explored as a production process by…
The growing demand for hazardous chemistry brings new risks that require both chemistry and engineering expertise
As new chemical entities (NCEs) with greater molecular complexity enter drug development pipelines, the demand for hazardous chemistry techniques is growing.
Hazardous chemistry can provide access to synthetic routes for active pharmaceutical ingredients (APIs) which overall involve fewer process stages. Whilst these alternative routes of synthesis are not always considered during the earlier phases of development due to the risks involved, they allow API manufacturers, with the right experience, to develop more direct and cost-effective processes that will produce higher yields.
In this article for Pharmaceutical Manufacturing, Paul Moscrop, Process Engineering Manager at Sterling Pharma Solutions analyses the requirement for hazard evaluation and the role of the process engineer when it comes to hazardous chemistry.
While widely adopted in other industries, continuous manufacturing is only just starting to be explored as a production process by…
A conversation with Kevin Cook about CDMO-sponsor partnerships and outsourcing Kevin Cook, CEO at Sterling Pharma Solutions recently spoke with…
View our infographic to explore the growth of highly potent molecules and key considerations to unlock their full potential in…
There is a growing demand for hazardous chemistry techniques for synthetic manufacturing processes, propelled by the increasing complexity of new…